{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:22:16Z","timestamp":1768371736238,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24541-3","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:14:15Z","timestamp":1768029255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Translational characterization of a house dust mite-induced murine model of dermatitis"],"prefix":"10.1038","volume":"16","author":[{"given":"Zhi","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samrawit","family":"Aforki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary K.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy H.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia E.","family":"Marinopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph B.","family":"Wetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Karsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Crosbie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Asque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gricelda","family":"Simler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie E.","family":"Paulsboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Ciura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyal","family":"Butt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heath A.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramkrishna","family":"Sadhukhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Todorovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria E.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Loud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"24541_CR1","first-page":"21","volume":"21","author":"T Bieber","year":"2022","unstructured":"Bieber, T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat. Rev. 21, 21\u201340 (2022).","journal-title":"Nat. Rev."},{"key":"24541_CR2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","volume":"151","author":"IV Schuler","year":"2023","unstructured":"Schuler, I. V., Billi, C. F., Maverakis, A. C., Tsoi, E. & Gudjonsson, L. C. Novel insights into atopic dermatitis. J. Allergy Clin. Immunol. 151, 1145\u20131154 (2023).","journal-title":"J. Allergy Clin. Immunol."},{"key":"24541_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0140-6736(22)02037-2","volume":"401","author":"E Guttman-Yassky","year":"2023","unstructured":"Guttman-Yassky, E. et al. An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicenter, double-blind, placebo-controlled phase 2b study. Lancet 401, 204\u2013214 (2023).","journal-title":"Lancet"},{"key":"24541_CR4","first-page":"389","volume":"90","author":"BC Martel","year":"2017","unstructured":"Martel, B. C., Lovato, P., Baumer, W. & Olivry, T. Translational animal models of atopic dermatitis for preclinical studies. Yale J. Biol. Med. 90, 389\u2013402 (2017).","journal-title":"Yale J. Biol. Med."},{"key":"24541_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jaci.2016.08.029","volume":"139","author":"DA Ewald","year":"2017","unstructured":"Ewald, D. A. et al. Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling. J. Allergy Clin. Immunol. 139, 562\u2013571 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"24541_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3390\/jcm10040613","volume":"10","author":"J Choi","year":"2021","unstructured":"Choi, J. et al. Translational relevance of mouse models of atopic dermatitis. J. Clin. Med. 10, 613\u2013713 (2021).","journal-title":"J. Clin. Med."},{"key":"24541_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.immuni.2022.07.008","volume":"55","author":"K Medetgul-Ernar","year":"2022","unstructured":"Medetgul-Ernar, K. & David, M. M. Standing on the shoulders of mice. Immunity 55, 1343\u20131353 (2022).","journal-title":"Immunity"},{"key":"24541_CR8","first-page":"e1369","volume":"17","author":"L Wang","year":"2023","unstructured":"Wang, L., Hu, D., Xu, J., Hu, J. & Wang, Y. Complex in vitro model: a transformational model in drug development and precision medicine. Clin. Transl Sci. 17, e1369\u201313701 (2023).","journal-title":"Clin. Transl Sci."},{"key":"24541_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.molmed.2010.04.008","volume":"16","author":"WR Thomas","year":"2010","unstructured":"Thomas, W. R., Hales, B. J. & Smith, W. A. House dust mite allergens in asthma and allergy. Trends Mol. Med. 16, 321\u2013328 (2010).","journal-title":"Trends Mol. Med."},{"key":"24541_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12016-018-8693-0","volume":"57","author":"JD Miller","year":"2019","unstructured":"Miller, J. D. The role of dust mites in allergy. Clin. Rev. Allergy Immunol. 57, 21\u201329 (2019).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"24541_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/intimm\/9.3.461","volume":"9","author":"H Matsuda","year":"1997","unstructured":"Matsuda, H. et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC\/Nga mice. Int. Immunol. 9, 461\u2013466 (1997).","journal-title":"Int. Immunol."},{"key":"24541_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1398-9995.2003.23790.x","volume":"58","author":"H Matsuoka","year":"2003","unstructured":"Matsuoka, H. et al. A mouse model of the atopic eczema\/dermatitis syndrome by repeated application of a crude extract of house-duct mite dermatophagoides Farinae. Allergy 58, 139\u2013145 (2003).","journal-title":"Allergy"},{"key":"24541_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000074903","volume":"132","author":"M Heishi","year":"2003","unstructured":"Heishi, M. et al. Gene expression analysis of atopic dermatitis-like skin lesions induced in NC\/Nga mice by mite antigen stimulation under specific pathogen-free conditions. Int. Arch. Allergy Immunol. 132, 355\u2013363 (2003).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"24541_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000446510","volume":"170","author":"M Jin","year":"2016","unstructured":"Jin, M. et al. 1,2,3,5-tetramethoxybenzene suppresses house dust mite-induced allergic inflammation in BALB\/c mice. Int. Arch. Allergy Immunol. 170, 35\u201345 (2016).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"24541_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jep.2017.06.001","volume":"206","author":"HY Cha","year":"2017","unstructured":"Cha, H. Y., Ahn, S. H., Cheon, J. H., Park, S. Y. & Kim, K. Hataedock treatment has preventive therapeutic effects for atopic dermatitis through skin barrier protection in dermatophagoides farinae-induced NC\/Nga mice. J. Ethnopharmacol. 206, 327\u2013336 (2017).","journal-title":"J. Ethnopharmacol."},{"key":"24541_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1084\/jem.20170536","volume":"215","author":"R Herro","year":"2018","unstructured":"Herro, R. et al. LIGHT-HVEM signaling in keratinocytes control development of dermatitis. J. Exp. Med. 215, 415\u2013422 (2018).","journal-title":"J. Exp. Med."},{"key":"24541_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2332\/allergolint.O-06-458","volume":"56","author":"M Yamamoto","year":"2007","unstructured":"Yamamoto, M. et al. A novel atopic dermatitis model induced by topical application with dermatophagoides Farinae extract in NC\/Nga mice. Allergol. Int. 56, 139\u2013148 (2007).","journal-title":"Allergol. Int."},{"key":"24541_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jdermsci.2016.12.015","volume":"86","author":"A Noguchi","year":"2017","unstructured":"Noguchi, A. et al. Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC\/Nga mice. J. Dermatol. Sci. 86, 54\u201362 (2017).","journal-title":"J. Dermatol. Sci."},{"key":"24541_CR19","doi-asserted-by":"publisher","first-page":"588543","DOI":"10.3389\/fimmu.2020.588543","volume":"11","author":"T Ge","year":"2020","unstructured":"Ge, T. et al. The JAK1 selective inhibitor ABT-317 blocks signaling through interferon-g and common g chain cytokine receptors to reverse autoimmune diabetes in NOD mice. Frontier Immunol. 11, 588543\u2013588554 (2020).","journal-title":"Frontier Immunol."},{"key":"24541_CR20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/jamadermatol.2021.3023","volume":"157","author":"A Blauvelt","year":"2021","unstructured":"Blauvelt, A. et al. Efficacy and safety of Upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis. JAMA Dermatol. 157, 1047\u20131055 (2021).","journal-title":"JAMA Dermatol."},{"key":"24541_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamadermatol.2022.6192","volume":"159","author":"AS Paller","year":"2023","unstructured":"Paller, A. S. et al. Efficacy and safety of dupilumab in patients with erythrodermic atopic dermatitis, a post hoc analysis of 6 randomized clinical trials. JAMA Dermatol. 159, 255\u2013266 (2023).","journal-title":"JAMA Dermatol."},{"key":"24541_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2340\/00015555-1879","volume":"95","author":"T Akiyama","year":"2015","unstructured":"Akiyama, T., Carstens, M. L., Piecha, D., Steppan, S. & Carstens, E. Nalfurafine suppresses pruritogen- and touch-evoked scratching behavior in models of acute and chronic itch in mice. Acta Derm Venereol. 95, 147\u2013150 (2015).","journal-title":"Acta Derm Venereol."},{"key":"24541_CR23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/1346-8138.14899","volume":"46","author":"L Leys","year":"2019","unstructured":"Leys, L. et al. Characterization of psoriasiform dermatitis induced by systemic injection of interleukin-23 minicircles in mice. J. Dermatol. 46, 482\u2013497 (2019).","journal-title":"J. Dermatol."},{"key":"24541_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jid.2015.11.001","volume":"136","author":"C Murray","year":"2016","unstructured":"Murray, C. et al. Use of canine model of atopic dermatitis to investigate the efficacy of CCR4 antagonist in allergen-induced skin inflammation in a randomized study. J. Invest. Dermatol. 136, 665\u2013671 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"24541_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jdermsci.2018.08.001","volume":"92","author":"SB Gauld","year":"2018","unstructured":"Gauld, S. B. et al. Mechanistic and Pharmacological assessment of murine IL-23 mediated psoriasiform dermatitis: implications for drug discovery. J. Dermatol. Sci. 92, 45\u201353 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"24541_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s41927-018-0031-x","volume":"2","author":"JM Parmentie","year":"2018","unstructured":"Parmentie, J. M. et al. In vitro and in vivo characterization of the JAK1 selectivity of Upadacitinib (ABT-494). BMC Rheumatol. 2, 23\u201333 (2018).","journal-title":"BMC Rheumatol."},{"key":"24541_CR27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/exd.13911","volume":"28","author":"M Moyle","year":"2019","unstructured":"Moyle, M., Cevikbas, F., Harden, J. L. & Guttman-Yassky, E. Understanding the immune landscape in atopic dermatitis: the era of biologics and emerging therapeutic approaches. Exp. Dermatol. 28, 756\u2013768 (2019).","journal-title":"Exp. Dermatol."},{"key":"24541_CR28","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1007\/s13555-023-01000-3","volume":"13","author":"JI Silverberg","year":"2023","unstructured":"Silverberg, J. I. et al. Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis. Dermatol. Ther. 13, 2247\u20132264 (2023).","journal-title":"Dermatol. Ther."},{"key":"24541_CR29","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jaci.2021.01.013","volume":"147","author":"Y Renert-Yuval","year":"2021","unstructured":"Renert-Yuval, Y. et al. Biomarkers in atopic dermatitis\u2014a review on behalf of the international eczema Council. J. Allergy Clin. Immunol. 147, 1174\u20131190 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"24541_CR30","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/jcm12062189","volume":"12","author":"F Gelato","year":"2023","unstructured":"Gelato, F. et al. Is dupilumab as effective in intrinsic atopic dermatitis as it is in extrinsic atopic dermatitis. J. Clin. Med. 12, 2189\u20132196 (2023).","journal-title":"J. Clin. Med."},{"key":"24541_CR31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/1523-1747.ep12345103","volume":"106","author":"U Hoffman","year":"1996","unstructured":"Hoffman, U., Tokura, Y., Nishijima, T., Takigawa, M. & Paus, R. Hair cycle-dependent changes in skin immune functions: anagen-associated depression of sensitization for contact hypersensitivity in mice. J. Invest. Dermatol. 106, 598\u2013604 (1996).","journal-title":"J. Invest. Dermatol."},{"key":"24541_CR32","doi-asserted-by":"publisher","first-page":"e22772","DOI":"10.7554\/eLife.22772","volume":"6","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. A multi-scale model for hair follicles reveals heterogeneous domains driving rapid Spatiotemporal hair growth patterning. Elife 6, e22772\u2013e22868 (2017).","journal-title":"Elife"},{"key":"24541_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.diff.2017.09.004","volume":"98","author":"G Salgado","year":"2017","unstructured":"Salgado, G., Ng, Y. Z., Koh, L. F., Goh, C. S. M. & Common, J. E. Human reconstructed skin xenografts on mice to model skin physiology. Differentiation 98, 14\u201324 (2017).","journal-title":"Differentiation"},{"key":"24541_CR34","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/s41590-019-0493-z","volume":"20","author":"N Serhan","year":"2019","unstructured":"Serhan, N. et al. House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation. Nat. Immunol. 20, 1435\u20131443 (2019).","journal-title":"Nat. Immunol."},{"key":"24541_CR35","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40261-020-00905-7","volume":"40","author":"G Agnihotri","year":"2020","unstructured":"Agnihotri, G. & Lio, P. A. Revisiting therapies for atopic dermatitis that failed clinical trials. Clin. Drug Invest. 40, 421\u2013431 (2020).","journal-title":"Clin. Drug Invest."},{"key":"24541_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","volume":"143","author":"T Czarnowicki","year":"2019","unstructured":"Czarnowicki, T., He, H., Krueger, J. G. & Guttman-Yassky, E. Atopic dermatitis endotypes and implications for targeted therapeutics. J. Allergy Clin. Immunol. 143, 1\u201311 (2019).","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24541-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:02:25Z","timestamp":1768345345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24541-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["24541"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24541-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1550"}}